Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Noguchi K, Mizobata S, Tamai M, Hotta T, Arii K, Terasawa H
WAKAYAMA SCH MED,DEPT SURG 2,WAKAYAMA 640,JAPAN.
Oncol Rep. 1996 Jan;3(1):45-8.
The autologous mixed lymphocyte reaction (AMLR) represents a self recognitive response, which is very important in the immunoregulatory network system. We investigated whether the AMLR activity of patients with gastric carcinoma could reflect the postoperative prognosis to clarify the significance of autoreactivity in anti-tumor immune system in cancer patients. The AMLR activity was suppressed both in the peripheral blood and in the spleen of patients with gastric carcinoma. The patients were divided into two groups; high responder and low responder group. The former consisted of patients whose AMLR activity was extremely suppressed, and the latter of patients whose AMLR activity was mildly suppressed. The survival rate and disease-free survival rate were generally higher in the high responder group than in the low responder group, especially in the spleen. Moreover, none of the patients in the high responder group for the AMLR activity in the spleen died within three years. These results indicated that the AMLR activity could reflect the prognosis of patients who received conventional curative operation. Therefore, it was suggested that the AMLR might be a useful parameter of postoperative prognosis in gastric cancer patients and that autoreactive T cells might play a pivotal role in auto-specific immunological control of tumor growth and metastases.
自体混合淋巴细胞反应(AMLR)代表一种自身识别反应,在免疫调节网络系统中非常重要。我们研究了胃癌患者的AMLR活性是否能反映术后预后,以阐明自身反应性在癌症患者抗肿瘤免疫系统中的意义。胃癌患者外周血和脾脏中的AMLR活性均受到抑制。患者被分为两组:高反应者组和低反应者组。前者由AMLR活性极度受抑制的患者组成,后者由AMLR活性轻度受抑制的患者组成。高反应者组的生存率和无病生存率通常高于低反应者组,尤其是在脾脏方面。此外,脾脏AMLR活性高反应者组中没有患者在三年内死亡。这些结果表明,AMLR活性可以反映接受传统根治性手术患者的预后。因此,提示AMLR可能是胃癌患者术后预后的一个有用参数,且自身反应性T细胞可能在肿瘤生长和转移的自身特异性免疫控制中起关键作用。